Healthcare -
Biotechnology - NASDAQ - US
$ 8.32
2.4 %
$ 316 M
Market Cap
14.0
P/E
TRDA - OTHER CURRENT ASSETS
Other Current Assets TRDA - Entrada Therapeutics, Inc.
16.4 M
LAST VALUE
-12.07%
2 YEAR CAGR
94.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR